Savara Pharmaceuticals
SVRA
#6474
Rank
NZ$0.98 B
Marketcap
$5.76
Share price
3.70%
Change (1 day)
-4.52%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -NZ$0.13 Billion

According to Savara Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$93.71 Million a decrease over its 2022 earnings that were of -NZ$65.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.13 Billion32.07%
2023 -NZ$93.71 Million43.38%
2022 -NZ$65.36 Million-11.31%
2021 -NZ$73.69 Million-13.3%
2020 -NZ$85 Million-36.53%
2019 -NZ$0.14 Billion13.76%
2018 -NZ$0.12 Billion105.54%
2017 -NZ$57.28 Million34.11%
2016 -NZ$42.71 Million-37.43%
2015 -NZ$68.26 Million38.81%
2014 -NZ$49.17 Million33.62%
2013 -NZ$36.8 Million38.49%
2012 -NZ$26.58 Million24.59%
2011 -NZ$21.33 Million-36.5%
2010 -NZ$33.59 Million-3.14%
2009 -NZ$34.68 Million-23.28%
2008 -NZ$45.2 Million8.52%
2007 -NZ$41.65 Million-34.14%
2006 -NZ$63.24 Million184.43%
2005 -NZ$22.24 Million90.75%
2004 -NZ$11.66 Million190.35%
2003 -NZ$4.02 Million11.64%
2002 -NZ$3.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$31.11 Million-75.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.42 Billion 224.94%๐Ÿ‡บ๐Ÿ‡ธ USA